Ad is loading...
ADIL
Price
$1.00
Change
-$0.02 (-1.96%)
Updated
Nov 22, 02:49 PM (EDT)
GDTC
Price
$2.25
Change
+$0.05 (+2.27%)
Updated
Nov 22, 02:07 PM (EDT)
5 days until earnings call
Ad is loading...

ADIL vs GDTC

Header iconADIL vs GDTC Comparison
Open Charts ADIL vs GDTCBanner chart's image
Adial Pharmaceuticals
Price$1.00
Change-$0.02 (-1.96%)
Volume$2.7K
CapitalizationN/A
CytoMed Therapeutics
Price$2.25
Change+$0.05 (+2.27%)
Volume$100
CapitalizationN/A
ADIL vs GDTC Comparison Chart
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ADIL vs. GDTC commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a Sell and GDTC is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ADIL: $1.02 vs. GDTC: $2.20)
Brand notoriety: ADIL and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 36% vs. GDTC: 18%
Market capitalization -- ADIL: $6.53M vs. GDTC: $25.51M
ADIL [@Biotechnology] is valued at $6.53M. GDTC’s [@Biotechnology] market capitalization is $25.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, GDTC is a better buy in the long-term than ADIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 4 TA indicator(s) are bullish.

  • ADIL’s TA Score: 4 bullish, 6 bearish.

Price Growth

ADIL (@Biotechnology) experienced а -10.53% price change this week, while GDTC (@Biotechnology) price change was +3.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

ADIL is expected to report earnings on Nov 13, 2023.

GDTC is expected to report earnings on May 05, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GDTC($25.5M) has a higher market cap than ADIL($6.53M). ADIL YTD gains are higher at: -45.161 vs. GDTC (-55.102).
ADILGDTCADIL / GDTC
Capitalization6.53M25.5M26%
EBITDA-8.13MN/A-
Gain YTD-45.161-55.10282%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash5.2MN/A-
Total Debt194KN/A-
FUNDAMENTALS RATINGS
ADIL: Fundamental Ratings
ADIL
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
68
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADIL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRX8.750.36
+4.29%
Xerox Holdings Corp
PZG0.380.01
+1.34%
Paramount Gold Nevada Corp
DOYU9.72-0.01
-0.10%
DouYu International Holdings Limited
ZBH108.40-0.87
-0.80%
Zimmer Biomet Holdings
AB36.72-0.45
-1.21%
AllianceBernstein Holding LP

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
N/A
SYRE - ADIL
39%
Loosely correlated
-1.82%
VANI - ADIL
36%
Loosely correlated
+3.10%
VTVT - ADIL
30%
Poorly correlated
-4.08%
BPMUF - ADIL
28%
Poorly correlated
N/A
GDTC - ADIL
27%
Poorly correlated
-0.46%
More

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-0.46%
CVKD - GDTC
29%
Poorly correlated
-3.38%
ADIL - GDTC
27%
Poorly correlated
N/A
TENX - GDTC
25%
Poorly correlated
+1.68%
QSI - GDTC
24%
Poorly correlated
-12.95%
RXRX - GDTC
23%
Poorly correlated
-4.80%
More